DocGo (DCGO) EBITDA (2020 - 2026)

DocGo (DCGO) has reported EBITDA for 7 consecutive years, with -$14.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBITDA fell 67.26% year-over-year to -$14.9 million; the TTM figure through Mar 2026 stood at -$187.2 million (down 69764.68% YoY), while the FY2025 annual figure was -$181.2 million, down 1018.61% from the prior year.
• EBITDA came in at -$14.9 million for Q1 2026 at DocGo, up from -$134.1 million in the prior quarter.
• The five-year high for EBITDA was $12.7 million in Q2 2022, with the low at -$134.1 million in Q4 2025.
• Average EBITDA over 5 years is -$7.8 million, with a median of $3.4 million recorded in 2022.
• Across the five-year window, EBITDA jumped 921.5% in 2022 and plunged 2979.99% in 2025, its largest moves.
• Year by year, EBITDA stood at $8.6 million in 2022, then decreased by 3.94% to $8.2 million in 2023, then tumbled by 152.8% to -$4.4 million in 2024, then slumped by 2979.99% to -$134.1 million in 2025, then jumped by 88.89% to -$14.9 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$14.9 million, -$134.1 million, and -$28.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.